A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder

NCT00960986 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

249

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder (MDD)

Interventions

DRUG: Duloxetine hydrochloride

Sponsor

Eli Lilly and Company

Collaborators

[object Object]